Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort.

AIDS (London, England) - 30 Mar 2001

Alexander C S, Dong W, Chan K, Jahnke N, O'Shaughnessy M V, Mo T, Piaseczny M A, Montaner J S, Harrigan P R

Abstract excerpt

OBJECTIVE: To assess the effect of baseline HIV reverse transcriptase (RT) and protease sequence variation on virologic outcomes in a large cohort of antiretroviral-naive patients in British Columbia, Canada. METHODS: Population sequencing of RT and protease was performed on baseline viral RNA of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to British Columbia
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Treatment Outcome

Source

Identifiers

PMID: 11316997
DOI: 10.1097/00002030-200103300-00009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-11316997-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort.PMID 11316997Read ↗

Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy.Semantic proximity Read ↗

Prevalence and Response to Antiretroviral Therapy of Non-B Subtypes of HIV in Antiretroviral-Naive Individuals in British ColumbiaSemantic proximity Read ↗

Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.Semantic proximity Read ↗

Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.Semantic proximity Read ↗

Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy.Semantic proximity Read ↗

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.Semantic proximity Read ↗

Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response.Semantic proximity Read ↗

Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapy.Semantic proximity Read ↗

The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.Semantic proximity Read ↗

Towards targeted screening for acute HIV infections in British Columbia.Semantic proximity Read ↗

Polymorphisms in HIV-1 subtype C proteases and the potential impact on protease inhibitors.Semantic proximity Read ↗

Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.